Construction of mouse CMKLR1 gene knock-down vascular smooth muscle cell lines mediated by lentivirus vector

doi:10.3969/j.issn.2095-4344.2015.20.015

Abstract

Abstract:

BACKGROUND: Levels of chemerin are elevated in arteriosclerosis, indicating chemerin and its receptor (CMKLR1) may participate in the pathological process of arteriosclerosis.
OBJECTIVE: To establish the stable CMKLR1 gene knock-down mouse vascular smooth muscle cell lines.
METHODS: Three shRNA sequences targeting the coding region of mouse CMKLR1 mRNA were synthesized and employed to construct lentivirus recombinant vectors. The best pLVX-shRNA was picked up to package recombinant lentivirus in 293T cells, which were infected in cultured mouse vascular smooth muscle cells. The CMKLR1 mRNA level of vascular smooth muscle cells was verified by real-time PCR.
RESULTS AND CONCLUSION: The lentiviral vectors were successfully constructed, which was confirmed by DNA sequencing. The titer of lentivirus reached 8.7×106 TU/mL in the packaging cells, and pLVX-shRNA3 showed the most significant interfering effects on CMKLR1 gene (P < 0.001). The pLVX-shRNA3 was chosen to establish the stable CMKLR1 gene knock-down vascular smooth muscle cell lines, in which the expression of CMKLR1 mRNA was also significantly inhibited shown on real-time PCR (P < 0.001). We finally confirmed that the expression of CMKLR1 gene can be effectively silenced by lentivirus-mediated siRNA in mouse mouse vascular smooth muscle cells.

Key words: Myocytes, Smooth Muscle, Chemotactic Factors , RNA Interference

CLC Number:

R318

Xiong Wei, Dong Shao-hong, Zhang Jian, Li Jiang-hua, Wu Mei-shan, Liao Bi-hong, Pang Xin-li,Luo Lin-jie. Construction of mouse CMKLR1 gene knock-down vascular smooth muscle cell lines mediated by lentivirus vector [J]. Chinese Journal of Tissue Engineering Research, doi: 10.3969/j.issn.2095-4344.2015.20.015.

Figures/Tables 2

References

[1] Golia E, Limongelli G, Natale F, et al.Adipose tissue and vascular inflammation in coronary artery disease.World J Cardiol. 2014;6(7):539-554.

[2] Ernst MC, Sinal CJ. Chemerin:at the crossroads of inflammation and obesity. Trends Endocrinol Metab. 2010; 21(11): 660-667.

[3] Spiroglou SG, Kostopoulos CG, Varakis JN,et al. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis.J Atheroscler Thromb.2010; 17(2):115-130.

[4] Dong B, Ji W, Zhang Y. Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Intern Med. 2011;50(10): 1093-1097.

[5] Ji Q, Lin Y, Liang Z,et al.Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris. Cardiovasc Diabetol. 2014;13:145.

[6] Dessein PH, Tsang L, Woodiwiss AJ,et al.Circulating concentrations of the novel adipokine chemerin are associated with cardiovascular disease risk in rheumatoid arthritis.J Rheumatol. 2014;441(9):1746-1754.

[7] Kostopoulos CG, Spiroglou SG, Varakis JN, et al.Chemerin and CMKLR1 expression in human arteries and periadventitial fat: a possible role for localchemerin in atherosclerosis?BMC Cardiovasc Disord. 2014;14:56.

[8] Owman C, Nilsson C, Lolait SJ.Cloning of cDNA encoding a putative chemoattractant receptor.Genomics. 1996;37(2): 187-194.

[9] Mattern A,Zellmann T,Beck-Sickinger AG.Processing, signaling,and physiological function of chemerin.IUBMB Life. 2014;66(1):19-26.

[10] Bondue B, Wittamer V, Parmentier M.Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism.Cytokine Growth Factor Rev. 2011;22(5-6): 331-338.

[11] Yoshimura T, Oppenheim JJ.Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties.Exp Cell Res. 2011;317(5):674-684.

[12] Wittamer V, Franssen JD, Vulcano M,et al.Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids.J Exp Med. 2003;198(7):977-985.

[13] Meder W, Wendland M, Busmann A, et al.Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23.FEBS Lett. 2003;555(3):495-499.

[14] Weigert J, Neumeier M, Wanninger J, et al.Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes.Clin Endocrinol. 2010;72(3):342-348.

[15] Kaur J, Adya R, Tan BK, et al.Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis. Biochem Biophys Res Commun. 2010;391(4): 1762-1768.

[16] Fatima SS, Rehman R, Baig M, et al.New roles of the multidimensional adipokine:chemerin.Peptides. 2014;62: 15-20.

[17] Mariani F, Roncucci L.Chemerin/chemR23 axis in inflammation onset and resolution.Inflamm Res. 2015;64(2): 85-95.

[18] Dong S, Xiong W, Yuan J,et al.MiRNA-146a regulates the maturation and differentiation of vascular smooth muscle cells by targeting NF-κB expression.Mol Med Rep. 2013;8(2): 407-412.

[19] Samson M, Edinger AL, Stordeur P, et al.ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains.Eur J Immunol.1998;28(5):1689-1700.

[20] Yoo HJ, Choi HY, Yang SJ, et al. Circulating Chemerin Level is Independently Correlated with Arterial Stiffness. J Atheroscler Thromb. 2012;19(1):59-68.

[21] 范书英,黎娜,于长安,等.冠心病患者血浆Chemerin水平的变化及其影响因素.临床心血管病杂志. 2012;28(1):31-33.

[22] Watts SW, Dorrance AM, Penfold ME,et al.Chemerin connects fat to arterial contraction. Arterioscler Thromb Vasc Biol. 2013;33(6):1320-1328.

[23] Lehrke M, Becker A, Greif M, et al.Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. Eur J Endocrinol.2009;161(2):339-344.